Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. RELL2 Rabbit anti-Human, Polyclonal, Novus Biologicals™

RELL2 Rabbit anti-Human, Polyclonal, Novus Biologicals™
SDP

Catalog No. NB096264 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μL
20 μL
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB096264 20 μL
NB096263 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. NB096264 Supplier Novus Biologicals Supplier No. NBP30504220UL

Description

Rabbit Polyclonal Antibody

RELL2 Polyclonal specifically detects RELL2 in Human samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.

Specifications

Antigen RELL2
Applications Immunohistochemistry
Classification Polyclonal
Conjugate Unconjugated
Formulation PBS with 50% glycerol, pH7.3.
Gene Alias C5orf16, chromosome 5 open reading frame 16, FLJ90583, receptor expressed in lymphoid tissues like 2, RELT-like 2, RELT-like protein 2
Host Species Rabbit
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 44-303 of human RELL2 (NP_776189.3).
Purification Method Affinity purified
Quantity 20 μL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 285613
Target Species Human
Content And Storage Store at -20°C. Avoid freeze-thaw cycles.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.